Hanmi Pharmaceutical Co., Ltd., Ten Percent Owner at Aptose Biosciences, holds 884.15K shares in Aptose Biosciences (Ticker: APTO). Most recently, Hanmi Pharmaceutical Co., Ltd. Bought $668,449 shares of Aptose Biosciences on Sep 08, 2023 for an estimated value of 3.00M.
What was Hanmi Pharmaceutical Co., Ltd.’s latest transaction?
Hanmi Pharmaceutical Co., Ltd. latest transaction was an Informative Buy of $3.00M.
What was Hanmi Pharmaceutical Co., Ltd.'s most profitable transaction?
Hanmi Pharmaceutical Co., Ltd.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Hanmi Pharmaceutical Co., Ltd.'s role in Aptose Biosciences?
Hanmi Pharmaceutical Co., Ltd.'s role in Aptose Biosciences is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.